首页> 美国卫生研究院文献>Clinical Molecular Pathology >Verotoxin and neuraminidase induced platelet aggregating activity in plasma: their possible role in the pathogenesis of the haemolytic uraemic syndrome.
【2h】

Verotoxin and neuraminidase induced platelet aggregating activity in plasma: their possible role in the pathogenesis of the haemolytic uraemic syndrome.

机译:维毒素和神经氨酸酶诱导血浆中的血小板聚集活性:它们在溶血性尿毒症综合征发病机理中的可能作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Certain strains of Escherichia coli producing verotoxin have been isolated in the stools of patients with the haemolytic uraemic syndrome. A platelet aggregating activity has been found in normal plasma after incubation with verotoxin at 37 degrees C for 24 h. This activity, unlike neuraminidase, has an effect that is independent of changing factor VIII related antigen, but requires the IIA and IIIB platelet surface glycoprotein (deficient in thrombasthenia) to mediate its effect. Prostacyclin totally inhibited this effect, but other antiplatelet drugs and heparin were without inhibitory effects.
机译:在溶血性尿毒症综合征患者的粪便中已分离出某些产生维毒素的大肠杆菌菌株。在37摄氏度下与维毒素孵育24小时后,在正常血浆中发现了血小板聚集活性。与神经氨酸酶不同,该活性具有独立于变化的因子VIII相关抗原的作用,但需要IIA和IIIB血小板表面糖蛋白(血栓减轻症)来介导其作用。前列环素完全抑制该作用,但其他抗血小板药物和肝素则无抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号